LabCorp's Liquid Yield Option(TM) Notes Due 2021 And Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Cash Interest

    BURLINGTON, N.C., March 19 /CNW/ -- Laboratory Corporation of America(R)
Holdings (LabCorp(R)) (NYSE:   LH) announced today that for the period of March
12, 2007 to September 11, 2007, its zero coupon subordinated Liquid Yield
Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated
Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the LYONs and
Zero Coupon Notes, accrue contingent cash interest at a rate of no less than
0.125% of the average market price of a LYON or Zero Coupon Note, as
applicable, for the five trading days ended March 7, 2007, in addition to the
continued accrual of the original issue discount. Contingent cash interest,
which the Company has determined to be approximately $1.22 per Note, will be
payable to holders of the LYONs or Zero Coupon Notes as of the record date,
which is August 27, 2007. The payment of contingent cash interest is expected
to be made on September 11, 2007.

    About LabCorp(R)
    Laboratory Corporation of America(R) Holdings, a S&P 500 company, is a
pioneer in commercializing new diagnostic technologies and the first in its
industry to embrace genomic testing.  With annual revenues of $3.6 billion in
2006, over 25,000 employees nationwide, and more than 220,000 clients, LabCorp
offers clinical assays ranging from routine blood analyses to HIV and genomic
testing. LabCorp combines its expertise in innovative clinical testing
technology with its Centers of Excellence: The Center for Molecular Biology
and Pathology, National Genetics Institute, Inc., ViroMed Laboratories, Inc.,
The Center for Esoteric Testing, DIANON Systems, Inc., US LABS, and Esoterix
and its Colorado Coagulation, Endocrine Sciences, and Cytometry Associates
laboratories.  LabCorp clients include physicians, government agencies,
managed care organizations, hospitals, clinical labs, and pharmaceutical
companies. To learn more about our growing organization, visit our Web site

    Each of the above forward-looking statements is subject to change based
on various important factors, including without limitation, competitive
actions in the marketplace and adverse actions of governmental and other
third-party payors.  Actual results could differ materially from those
suggested by these forward-looking statements. Further information on
potential factors that could affect LabCorp's financial results is included in
the Company's Form 10-K for the year ended December 31, 2006, and subsequent
SEC filing.

For further information:

For further information: Investor Contact: Scott Fleming,
+1-336-436-4879,  or media contact: Pam Sherry, +1-336-436-4855, or
shareholder direct:  +1-800-LAB-0401 Web Site:

Organization Profile


More on this organization


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890